News and information from our partners

Smallpox drug is terror remedy

CORVALLIS (AP) — A Corvallis-based company that has developed a drug to treat smallpox as part of U.S. defenses against terror and biological attacks says it has qualified for an initial payment of about $79 million.

The money, when it arrives, will be the first cash payment for a deliverable product ever received by Siga Technologies, which has been working to bring a drug to market since its founding in 1995. Siga’s Corvallis laboratories employ about 70 scientists and technicians.


Use the comment form below to begin a discussion about this content.

Sign in to comment


Information from The Chronicle and our advertisers (Want to add your business to this to this feed?)